![Heiko von der Leyen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Heiko von der Leyen is currently the Medical Director at Orgenesis, Inc. He previously worked as the Managing Director at Hannover Clinical Trial Center GmbH from 2005 to 2017.
Prior to that, he was the Medical Director & VP-Clinical Development at Cardion GmbH from 1998 to 2001.
He also served as the Chief Scientific Officer at Avontec GmbH in 2003 and at Artiss GmbH in 2001-2002.
Postes actifs de Heiko von der Leyen
| Sociétés | Poste | Début |
|---|---|---|
| ORGENESIS INC. | Directeur Technique/Scientifique/R&D | 01/09/2020 |
Anciens postes connus de Heiko von der Leyen
| Sociétés | Poste | Fin |
|---|---|---|
Hannover Clinical Trial Center GmbH | Corporate Officer/Principal | 01/01/2017 |
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Artiss GmbH | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Directeur Technique/Scientifique/R&D | 01/01/2001 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Orgenesis, Inc.
 Orgenesis, Inc. Operates as a development stage company, which focuses on treatment of diabetes. | |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Health Technology |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
Hannover Clinical Trial Center GmbH | |
Artiss GmbH |
